Cargando…

Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom

Despite the clinical and financial implications, there is little evidence about how patients who have been treated for soft tissue sarcoma should be followed up. The purpose of this study was to determine current practice in the United Kingdom. 192 clinicians treating patients with soft tissue sarco...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerrand, C. H., Billingham, L. J., Woll, P. J., Grimer, R. J.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225460/
https://www.ncbi.nlm.nih.gov/pubmed/18270541
http://dx.doi.org/10.1155/2007/34128
_version_ 1782149660234743808
author Gerrand, C. H.
Billingham, L. J.
Woll, P. J.
Grimer, R. J.
author_facet Gerrand, C. H.
Billingham, L. J.
Woll, P. J.
Grimer, R. J.
author_sort Gerrand, C. H.
collection PubMed
description Despite the clinical and financial implications, there is little evidence about how patients who have been treated for soft tissue sarcoma should be followed up. The purpose of this study was to determine current practice in the United Kingdom. 192 clinicians treating patients with soft tissue sarcoma were surveyed with a postal questionnaire enquiring about frequency and method of follow up and how patients would be followed up in each of 3 clinical scenarios: a patient with a trunk or extremity tumour at low risk of relapse; a patient with a trunk or extremity tumour at high risk of relapse; and a patient with a retroperitoneal or abdominal tumour. 155 (81%) clinicians responded. Clinic visits and X-rays were the most frequently used methods of follow up. Chest CT scans, local site imaging, and blood tests were used infrequently. The intensity and methods of follow up varied with each of the clinical scenarios. There was a seven-to-twenty fold variation in cost between the least and the most expensive regimes. Respondents were generally supportive of the development of the clinical trial in this area.
format Text
id pubmed-2225460
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-22254602008-02-12 Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom Gerrand, C. H. Billingham, L. J. Woll, P. J. Grimer, R. J. Sarcoma Research Article Despite the clinical and financial implications, there is little evidence about how patients who have been treated for soft tissue sarcoma should be followed up. The purpose of this study was to determine current practice in the United Kingdom. 192 clinicians treating patients with soft tissue sarcoma were surveyed with a postal questionnaire enquiring about frequency and method of follow up and how patients would be followed up in each of 3 clinical scenarios: a patient with a trunk or extremity tumour at low risk of relapse; a patient with a trunk or extremity tumour at high risk of relapse; and a patient with a retroperitoneal or abdominal tumour. 155 (81%) clinicians responded. Clinic visits and X-rays were the most frequently used methods of follow up. Chest CT scans, local site imaging, and blood tests were used infrequently. The intensity and methods of follow up varied with each of the clinical scenarios. There was a seven-to-twenty fold variation in cost between the least and the most expensive regimes. Respondents were generally supportive of the development of the clinical trial in this area. Hindawi Publishing Corporation 2007 2007-12-26 /pmc/articles/PMC2225460/ /pubmed/18270541 http://dx.doi.org/10.1155/2007/34128 Text en Copyright © 2007 C. H. Gerrand et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gerrand, C. H.
Billingham, L. J.
Woll, P. J.
Grimer, R. J.
Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom
title Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom
title_full Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom
title_fullStr Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom
title_full_unstemmed Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom
title_short Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom
title_sort follow up after primary treatment of soft tissue sarcoma: a survey of current practice in the united kingdom
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225460/
https://www.ncbi.nlm.nih.gov/pubmed/18270541
http://dx.doi.org/10.1155/2007/34128
work_keys_str_mv AT gerrandch followupafterprimarytreatmentofsofttissuesarcomaasurveyofcurrentpracticeintheunitedkingdom
AT billinghamlj followupafterprimarytreatmentofsofttissuesarcomaasurveyofcurrentpracticeintheunitedkingdom
AT wollpj followupafterprimarytreatmentofsofttissuesarcomaasurveyofcurrentpracticeintheunitedkingdom
AT grimerrj followupafterprimarytreatmentofsofttissuesarcomaasurveyofcurrentpracticeintheunitedkingdom